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Sphingoid bases have been implicated in various cellular processes including cell growth, apoptosis and cell differen-
tiation. Here, we show that the regulated turnover of sphingoid bases is crucial for cell polarity development, i.e., the
biogenesis of apical plasma membrane domains, in well-differentiated hepatic cells. Thus, inhibition of dihydroceramide
synthase or sphinganine kinase activity with fumonisin B1 or N,N-dimethylsphingosine, respectively, dramatically
perturbs cell polarity development, which is due to increased levels of sphinganine. Consistently, reduction of free
sphinganine levels stimulates cell polarity development. Moreover, dihydroceramide synthase, the predominant enzyme
responsible for sphinganine turnover, is a target for cell polarity stimulating cAMP/protein kinase A (PKA) signaling
cascades. Indeed, electrospray ionization tandem mass spectrometry analyses revealed a significant reduction in sphin-
ganine levels in cAMP/PKA-stimulated cells. These data suggest that sphinganine turnover is critical for and is actively
regulated during HepG2 cell polarity development. Previously, we have identified an apical plasma membrane-directed
trafficking pathway from the subapical compartment. This transport pathway, which is part of the basolateral-to-apical
transcytotic itinerary, plays a crucial role in apical plasma membrane biogenesis. Here, we show that, as a part of the
underlying mechanism, the inhibition of dihydroceramide synthase activity and ensuing increased sphinganine levels
specifically perturb the activation of this particular pathway in the de novo apical membrane biogenesis.
INTRODUCTION
Epithelial cell polarity depends on the structural asymmetry
of apical and basolateral plasma membrane (PM) domains,
separated by junctional complexes. The establishment and
maintenance of PM domains requires a careful orchestration
of extra- and intracellular signals, triggering crucial or-
ganelle- and membrane traffic-linked machineries (Yeaman
et al., 1999; Mostov et al., 2003). Hepatocytes, like all epithe-
lia, display distinct apical, bile canalicular (BC) and basolat-
eral, sinusoidal PM domains. Some of the intracellular sites
and molecular components of the mechanisms that contrib-
ute to apical BC biogenesis in hepatocytes have been clari-
fied. These include E-cadherin (Terry and Gallin, 1994; Mat-
sui et al., 2002), cAMP/protein kinase (PK)A and PKC
activities (Roelofsen et al., 1998; Zegers and Hoekstra, 1998),
the cytoskeleton (Mishra et al., 1999), and the sorting of
specific sphingolipids and proteins, mediated by the Golgi
and endosomal recycling system (Zegers and Hoekstra,
1998; Ait Slimane and Hoekstra, 2002; Maier and Hoekstra,
2003). In particular, the subapical compartment (SAC), the
hepatocyte equivalent of the common endosome in other
epithelia, plays a central role in the polarized trafficking of
proteins (Ihrke et al., 1998; van IJzendoorn et al., 1998; Rahner
et al., 2000; Silver et al., 2001; Wu¨stner et al., 2004), sphingo-
lipids (van IJzendoorn and Hoekstra, 1998, 1999b, 2000;
Maier and Hoekstra, 2003), and cholesterol (Silver et al.,
2001; Wu¨stner et al., 2001, 2002, 2004).
Studies of the intracellular flow of fluorescent lipid ana-
logs indicated the existence of multiple membrane domains
in SAC, and the membrane sorting capacity of the SAC was
demonstrated to be a target for signals that promote apical-
basolateral PM asymmetry, including cAMP/PKA and the
interleukin-6 family cytokine oncostatin M (van IJzendoorn
et al., 2000; van der Wouden et al., 2002). Thus, during cell
polarity development and/or upon stimulation of cAMP/
PKA signaling in well-differentiated hepatic HepG2 cells, a
specific SAC-to-BC pathway followed by transcytosing IgA
and two fluorescent sphingolipid analogs, C6-NBD-sphingo-
myelin (SM) and -galactosylceramide (GalCer), and distinct
from the apical PM recycling route marked by the flow of
C6-NBD-glucosylceramide (GlcCer), is activated. Blocking
this pathway, e.g., with PKA inhibitors or the microtubule-
disrupting agent nocodazole effectively perturbs polarity
development. After the establishment of apical-basolateral
cell polarity, the trafficking of C6-NBD-SM and -GalCer from
SAC switches from an apical to a basolateral destination,
whereas the apical recycling of C6-NBD-GlcCer remains un-
affected. Fluorescent lipid analogs are thus a useful tool in
living cells to monitor intracellular trafficking pathways, and
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alterations in these, that are relevant for cell polarity devel-
opment.
Sphingolipids, together with cholesterol, cluster to form
particularly ordered membrane environments or rafts, in
which apical proteins and/or signal transduction molecules
are coassembled (Simons and Ikonen, 1997; Aı¨t Slimane et
al., 2003). Therefore, the lateral dynamics and organization
of sphingolipids may play a prominent role in the regulation
of signaling cascades and cell polarity (Holthuis et al., 2001).
Indeed, the segregation of predominantly apical PM pro-
teins into sphingolipid-enriched rafts suggests a prominent
role for sphingolipids in apical sorting (Simons and Ikonen,
1997). Moreover, the timely regulated activity of enzymes in
the sphingolipid biosynthesis pathway is crucial for cellular
development, e.g., that of polarized neurons (Futerman,
1998; Schwarz and Futerman, 1998; Ledesma et al., 1999;
Boldin and Futerman, 2000). For example, the expression of
sphingomyelin in developing neurons coincides with the
segregation of Thy-1 into sphingolipid rafts and its subse-
quent directed trafficking to the axonal plasma membrane
domain (Ledesma et al., 1999).
In addition to achieving specific expression levels of com-
plex (glyco)sphingolipids such as SM, GlcCer, and GalCer,
the regulated activity of enzymes that control their biosyn-
thesis also may serve to control the levels and activity of its
precursors. Indeed, ceramide (CER) and the sphingoid base
backbones of sphingolipids, i.e., sphingosine and sphinga-
nine (dihydro-sphingosine), seem highly bioactive com-
pounds that mediate membrane second messenger cascades
in the regulation of cell proliferation, apoptosis, and differ-
entiation (Shayman, 2000; Hannun et al., 2001) and, as re-
cently reported, membrane traffic (Friant et al., 2000, 2001;
Zanolari et al., 2000). Down-regulation of the expression
levels of sphingoid bases is typically achieved by incorpo-
rating these in higher sphingolipids or by their phosphory-
lation by sphingosine/sphinganine kinase. Not surprisingly,
alterations in the cellular levels of free sphingoid bases have
been implicated in various diseases, including hepatocellu-
lar carcinogenesis (Spiegel and Merrill, 1996), which arises
from dedifferentiation of mature hepatocytes (Bralet et al.,
2002; Gournay et al., 2002). However, no data are available as
to the involvement of free sphingoid bases in cell polarity
development. In this study, we demonstrate that the pre-
dominant enzyme involved in sphingoid base turnover, di-
hydroceramide synthase (sphinganine N-acyltransferase), is
a target for cell polarity-stimulating signaling cascades and
that the ability of cells to metabolize sphinganine is essential
for regulated polarized membrane trafficking from the SAC
and cell polarity development.
MATERIALS AND METHODS
Hoechst-33250 (bisbenzimide), l-cycloserine, and Fumonisin B1 were ob-
tained from Sigma-Aldrich (St. Louis, MO). d-erythro-Sphinganine, l-threo-
sphinganine (safingol), d-erythro-sphinganine-1-phosphate, and N,N-Dimeth-
yl-d-erythro-sphingosine were from Avanti Polar Lipids (Alabaster, AL).
Dibutyryl cAMP was purchased from Roche Diagnostics (Mannheim, Ger-
many). Albumin (from bovine serum, fraction V) was bought from Fluka
(Buchs, Switzerland). 6-[N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)-amino]hex-
anoic acid (C6-NBD) and Alexa594-labeled phalloidin were purchased from
Molecular Probes (Eugene, OR). Sodium dithionite (Na2S2O4) was from
Merck (Darmstadt, Germany). C6-NBD-sphingolipids were synthesized as
described previously (Kishimoto, 1975; Babia et al., 1994). Texas Red (TxR)-
labeled IgA was kindly provided by Dr. K. Dunn (Indiana University Medical
Center, Indianapolis, IN). All other chemicals were of analytical grade.
Cell Culture
HepG2 cells were cultured in high glucose (4500 mg/l) DMEM, supple-
mented with 10% heat-inactivated fetal calf serum (56°C; 30 min), l-glu-
tamine, and antibiotics (penicillin/streptomycin) at 37°C in a 5% CO2-humid-
ified incubator, as described previously (van IJzendoorn and Hoekstra, 1998).
Cells were plated onto ethanol-sterilized glass coverslips and cultured for 3 d
for cell polarity to develop. Cell polarity development in HepG2 cells is
characterized by the appearance of microvilli-lined apical vacuoles (resem-
bling BC) that occur in between two adjacent cells (Zegers and Hoekstra,
1997). The establishment of HepG2 cells that stably express the polymeric Ig
receptor has been described previously (van IJzendoorn and Hoekstra, 1998).
Determination of HepG2 Cell Polarity Development
HepG2 cell polarity development was determined by fluorescent microscop-
ical (AX70; Olympus, Tokyo, Japan) analysis of the ratio BC/100 cells as
described previously (van IJzendoorn and Hoekstra, 1999, 2000). BC were
identified by the dense F-actin staining (Alexa594-labeled phalloidin) that
surrounds the BC, and DNA was stained with Hoechst to facilitate cell
counting. Identical results were obtained when BC were identified by immu-
nofluorescent labeling of resident apical proteins such as MDR1, DPPIV, or
APN (Aı¨t Slimane et al., 2003). Data are expressed as mean  SEM of at least
three independent experiments, carried out in duplicate.
Quantification of Cellular Sphingolipid Levels by Tandem
Mass Spectrometry
Ceramide species were quantified by electrospray ionization tandem mass spec-
trometry (ESI-MS/MS) by the principle described previously with some modi-
fications (Liebisch et al., 1999). In brief, CER was analyzed by direct flow injection
analysis using an HTS PAL autosampler (Zwingen, Switzerland) and an Agilent
1100 binary pump (Waldbronn, Germany), providing a constant flow of metha-
nol 10 mM ammonium acetate:chloroform (3:1). The CER-specific daughter ion of
m/z 264 was used for mass spectrometric detection (Quattro Ultima; Micromass,
Manchester, United Kingdom). Quantification was achieved by addition of nat-
urally occurring CER species by using CER 17:0 as a not naturally occurring
internal standard. (In a similar way glucosylceramide was measured by the
collision-induced generation of m/z 264).
Sphingomyelin was quantified by a parent scan of m/z 184 and using no
naturally occurring phosphatidylcholine (PC) species PC 28:0 and PC 44:0 as
internal standards (Bru¨gger et al., 1997). Overlapping PC and SM isotope
species were corrected by a self-programmed isotope correction algorithm
based on calculated isotope distributions. The detailed methodology will be
published in a separate manuscript.
Sphingosine and sphinganine were quantified as described previously (Lieser
et al., 2003) by using the instrumentation described above, except for that SDS
lysates were used. An effect of the SDS lysis on quantification was excluded
because the calibration lines were made in the same sample matrix, which will
compensate any possible effect on the analytical response due to the use of SDS.
Moreover, additional peaks resulting from the SDS were not observed.
In all experiments a combination of MassLynx software, including the
NeoLynx tool (Micromass) and self-programmed Excel macros was used for
automated data processing. All data are expressed as mean  SEM of tripli-
cate experiments.
Dihydroceramide (DHC) Synthase Assay
The dyhydroceramide synthase assay was performed as described by Merrill and
Wang (1992). Cells, control or treated with dibutyryl cAMP (dbcAMP) for 30 min,
were scraped, and homogenized in sucrose buffer by sonication. DHC synthase
activity was measured in 500  103 cells (100 g) by using 1 M (100
pmol/100 g of cell protein) [3H]sphinganine and 100 M stearyl-CoA as sub-
strate in the presence or absence of 10 M FB1 for 0 or 10 min at 37°C. As an
additional control, stearyl-CoA was omitted from the reaction. The reaction was
terminated with CHCL3:methanol [1:2 (vol/vol)], and lipids were extracted with
CHCl3:methanol and separated by thin-layer chromatography (TLC). Radiola-
beled sphinganine and (dihydro)ceramides were scraped from the TLC plates
and quantified in a liquid scintillation counter (Veldman et al., 1998). Data are
expressed as picomoles per 100 g of protein and as percentage of control.
Transport of C6-NBD-GalCer from the SAC
To monitor SAC-associated sphingolipid transport, lipid is first accumulated
in the SAC, according to a procedure described elsewhere (van IJzendoorn
and Hoekstra 1998, 2000). First, cells were washed with PBS and incubated
with C6-NBD-GalCer at 37°C for 30 min to allow internalization of the lipid
analogue from the basolateral surface and transcytosis (van IJzendoorn and
Hoekstra, 1998). The remaining basolateral pool of lipid analogue was then
depleted by a back-exchange procedure [5% (wt/vol) bovine serum albumin
in Hanks’ balanced salt solution (HBSS), pH 7.4, at 4°C twice for 30 min]. Then
the lipid was chased from the apical, bile canalicular PM into the SAC by an
incubation at 18°C in back-exchange medium. The chase was done over a
60-min period and at this time, the majority of the lipid analogue was
associated with the SAC (cf. van IJzendoorn and Hoekstra, 1998). Any NBD
fluorescence still remaining at the luminal leaflet of the apical PM after the
60-min chase was subsequently abolished by incubating the cells with 30 mM
Na2S2O4 at 4°C, a condition that precludes intracellular access of the
quencher. After 10 min, Na2S2O4 was then removed by extensive washing of
the cells with ice-cold HBSS. In some experiments, cells were then treated
S.C.D. van IJzendoorm et al.
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with dbcAMP and/or sphinganine at 4°C for 30 min. Transport of the lipid
analogue from the SAC was subsequently monitored by incubation in back-
exchange medium at 37°C. When required, dbcAMP and/or sphinganine
were kept present during the transport assay.
To quantitate transport of the lipid analogue to and from the apical, BC
membranes, the percentage of NBD-positive BC membranes was determined
as described previously (van IJzendoorn et al., 1997; van IJzendoorn and
Hoekstra, 1998). Thus, BC were first identified by phase-contrast illumination
and then classified as either NBD positive or NBD negative under epifluo-
rescence illumination. Distinct pools of fluorescence were discerned, present
in vesicular structures adjacent to BC, which have been defined as SAC (cf.
van IJzendoorn and Hoekstra, 1998). Together, BC and SAC thus constitute
the bile canalicular, apical pole (BCP) in HepG2 cells. Therefore, within the
BCP region the localization of the fluorescent lipid analogues will be defined
as being derived from BC, SAC, or both. This also provides a means to
describe the movement of the lipid within or out of this region in the cell.
Thus, after loading the SAC with lipid analogue and a subsequent incubation
as described above, the direction of movement of the lipid analogue from or
within the BCP region is inferred from determining the fraction of NBD-
labeled BCP (i.e., label in either the BC or SAC or both) at a given time,
relative to that labeled when starting the chase (t  0). At least 50 BCPs per
coverslip were analyzed. Data are expressed as the mean  SEM of at least
three independent experiments, carried out in duplicate.
Internalization of Texas Red-labeled IgA
HepG2 cells that stably express pIgR were washed and asialoglycoprotein
receptors were saturated with excess asialofetuin at 37°C for 30 min to
prevent uptake of IgA via these receptors (cf. van IJzendoorn and Hoekstra,
1998). Cells, treated with sphinganine (2 M; 37°C for 1 h) were incubated
with TxR-IgA (50 g/ml) at 18°C for 60 min. Cells were then washed to
remove nonbound TxR-IgA and further incubated at 37°C for 30 min in the
presence or absence of sphinganine.
RESULTS
Sphinganine Accumulation Blocks Polarity Development
To examine the involvement of sphingolipid metabolites in
the process of hepatocyte polarity development, we used the
mycotoxin fumonisin B1 (FB1), which specifically inhibits
DHC synthase activity in the sphingolipid biosynthetic
pathway (Figure 1). Quantification of cellular sphingolipids
and sphingoid bases was performed by ESI-MS/MS as de-
scribed in Materials and Methods and in Lieser et al. (2003). As
anticipated, treatment of well-differentiated hepatoma
HepG2 cells with FB1 (10 M; 24 h) resulted in decreased
levels of ceramides, sphingomyelin, and glucosylceramide
(Table 1). Consequently, the level of the sphingoid base
sphinganine increased more than fivefold (4.1  1.0–23.0 
12.0 pmol/mg cell protein; Table 1; Lieser et al., 2003). To
examine potential consequences on HepG2 cell polarity de-
velopment, i.e., the biogenesis of apical BC, cells were plated
on coverslips in the presence of 0–30 M FB1. Each day, a
coverslip was taken and the ratio BC/100 cells was deter-
mined as a measure for cell polarity (see Materials and Meth-
ods). Control HepG2 cells rapidly acquired polarity, reaching
Figure 1. Scheme of the sphingolipid metabolic
pathway and sites of action of the distinct sphin-
golipid synthesis inhibitors. FB1, LCS, and DMS
inhibit the activity of dihydroceramide synthase,
serine palmitoyl transferase, and sphingosine/
sphinganine kinase, respectively.
Table 1. Quantification of sphingolipids in control versus FB1-
treated cells
Control (nmol/mg
protein)
FB1 (nmol/mg
protein)
SM 21.9  5.4 8.7  0.8
GlcCer 0.09 0.02 0.03 0.02
Cer 0.9  0.2 0.2 0.03
SA 0.0041  0.001 0.023  0.012
SO 0.042  0.01 0.016 0.004
Cells were cultured in normal culture medium in the presence of 10
M FB1 or buffer (control) for 24 h. Cells were then lysed in 0.5%
SDS lysis buffer, and lysates were immediately frozen at20°C. The
protein content of each sample was determined, and SM, GlcCer,
Cer, sphinganine (SA), and sphingosine (SO) were quantified as
described in Materials and Methods. All data are expressed as mean
SEM nanomoles per milligram of total cell protein of triplicate
experiments (n  3).
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a maximum ratio BC/100 cells 2 d after plating (Figure 2A).
By contrast, cells grown in the presence of FB1 showed a
dramatic inhibition of the formation of BC in a dose-depen-
dent manner, resulting in a reduction of the number of
polarized cells by75% 2 d after plating (Figure 2, A and B).
The inhibitory effect of FB1 on BC formation was reversible.
Thus, after 24 h of culturing in the presence of FB1 and
subsequent removal of the compound, polarity develop-
ment was rapidly restored (Figure 2A, dashed line). With the
concentrations of FB1 used, we did not observe significant
effects on cell viability (trypan blue exclusion; unpublished
data), or overall morphology, including cell attachment and
spreading. Importantly, the addition of 0.5–2.0 M sphinga-
nine upon plating the cells inhibited HepG2 cell polarity
development in a dose-dependent manner (Figure 2C),
thereby closely mimicking the effect of FB1 (Figure 2A).
Addition of 0.5 M sphinganine for 24 h resulted in an
increase in cellular sphinganine levels by 20-fold (from
4.0–90.0 pmol/mg cell protein; Table 2). Similar to as with
FB1, cell polarity was rapidly restored upon removal of the
exogenous sphinganine (Figure 2C, dashed line). These data
suggest that the accumulation of sphinganine, rather than
the inhibition of de novo synthesis of ceramides and/or
complex sphingolipids, was responsible for the observed
impediment of cell polarity development. Indeed, the inhib-
itory effect of FB1 on polarity development could not be
restored when FB1-treated cells were replenished with 10
M C6-DHC (Figure 2D) or short-chain ceramides (unpub-
lished data), analogs that were previously shown to restore
FB1-mediated effects due to decreased levels of complex
sphingolipids (Puglielli et al., 2003).
It should be noted that long-term incubation of 3T3 fibro-
blasts with FB1 was reported to up-regulate the activity of
enzymes that produce glucosylceramide and sphingomyelin
(Meivar-Levy and Futerman, 1999), both of which have been
implicated in differentiation and maturation of specialized
plasma membranes in neurons (Futerman et al., 1999;
Ledesma et al., 1999). Treatment of HepG2 cells with FB1
under our conditions, however, did not up-regulate glu-
cosylceramide synthase or sphingomyelin synthase (unpub-
lished data). Furthermore, although treatment of cells with
FB1 predominantly increases sphinganine levels (Table 1), it
has been reported to modestly increase cellular levels of
sphingosine (dihydro-sphinganine; Lieser et al., 2003). In
HepG2 cells, however, treatment of cells with FB1 (10 M)
resulted in a decrease in sphingosine levels; Table 1). More-
over, the exogenous addition of sphingosine did not alter
polarity development of HepG2 cells (Figure 3A), in striking
contrast to the exogenous addition of sphinganine (Figure
2C). Importantly, the exogenous addition of equal concen-
trations of hydrophobic amines NH4Cl and stearylamine did
not affect polarity development (Figure 3A), indicating that
the exogenously administered sphinganine did not inhibit
polarity development via its potential activity as a hydro-
phobic amine. In addition, the nonnatural stereoisomer of
Figure 2. Accumulation of sphinganine in-
hibits HepG2 cell polarity development. Cells
were treated with different concentrations of
FB1, FB1  DHC, or exogenous d-erythro-
sphinganine (SA) in serum-supplemented cell
culture medium for 24, 48, or 72 h. At each
time point, the cells were fixed and the ratio
BC/100 cells was determined as described in
Materials and Methods. Effect of 0–30 M FB1
(A and B), 0.5–2.0 M sphinganine (SA; C), or
30 M FB1  10 M DHC (D) on cell polarity
development. The dashed lines in A and C
(Rsc) show the course of polarity develop-
ment after removal of FB1 or exogenous sph-
inganine, respectively, after 24 h. Data are
expressed as mean  SEM of at least three
independent experiments carried out in du-
plicate. (B) Fluorescence microscopical evalu-
ation of cell polarity in control or FB1-treated
cells (72 h; nuclei in blue and BC in red). Note
the absence of BC in FB1-treated cultures.
Bars, 5 m; *p  0.05 (Student’s t test).
Table 2. Quantification of cellular sphinganine levels by ESI-
MS/MS
Sphinganine (% of control)
Control 100 ( 4.1 pmol/mg protein)
FB1 561
Exogenous SA 2219
LCS 73
DbcAMP 37
Quantification of sphinganine levels in HepG2 cells. Cells were
cultured in normal culture medium in the presence of 10 M FB1,
0.5 M exogenous d-erythro-sphinganine (SA), 250 M l-LCS, or 100
M dbcAMP for 24 h. Cells were then lysed in 0.5% SDS lysis buffer,
and lysates were immediately frozen at 20°C. The protein content
of each sample was determined and sphinganine levels were quan-
tified by ESI-MS/MS analysis as described in Materials and Methods.
Data were calculated as mean  SEM picomoles per milligram of
total cell protein of triplicate experiments (n  3) and expressed as
percentage of control (4.1 pmol/mg protein; set to 100).
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sphinganine, l-threo-sphinganine (safingol) did not mimic
the effects of FB1 or exogenous (d-erythro-)sphinganine (Fig-
ure 3A).
Together, the data indicate that dihydroceramide synthase
inhibition and subsequent accumulation of d-erythro-sphin-
ganine inhibits the establishment of HepG2 cell polarity.
Sphinganine and Not Sphinganine-1-Phosphate Interferes
with Polarity Development
On its accumulation, free sphinganine can be phosphory-
lated by sphingosine/sphinganine kinase to form sphinga-
nine-1-phosphate. Phosphorylated sphingoid bases are
highly bioactive compounds that can elicit various signaling
cascades in cells. To determine whether the observed effect
of FB1 or exogenous sphinganine on cell polarity develop-
ment was the result of the phosphorylated product, cells
were incubated with FB1 in the presence of N,N-dimethyl-
sphingosine (DMS; 2–5 M), an inhibitor of sphingosine/
sphinganine kinase (Figure 1). As shown in Figure 3B, DMS
did not prevent the effects of FB1 on polarity development.
Rather, inhibition of sphinganine kinase activity augmented
the inhibitory effect of FB1 on polarity development, and
treatment of the cells with DMS alone inhibited polarity
development to a similar extent as FB1 (Figure 3B). In addi-
tion, treatment of the cells with d-erythro-sphinganine-1-
phosphate (5 M) did not mimic the effects of sphinganine
(Figure 3B). Together, these data suggest that the accumu-
lation of sphinganine, and not of sphinganine-1-phosphate,
perturbs polarity development in HepG2 cells.
Sphinganine Turnover Promotes Polarity Development
To obtain further support for a direct correlation between
sphinganine level and cell polarization, we next investigated
whether decreased levels of this sphingolipid metabolite
also affect cell polarity development. A specific inhibitor of
serine palmitoyltransferase, l-cycloserine (LCS), inhibits
sphinganine biosynthesis (Figure 1). Indeed, the treatment
of HepG2 cells with 250 M LCS, in contrast to FB1, resulted
in a reduction of the cellular sphinganine level with 27%
(Table 2). Interestingly, in striking contrast to the effect of
FB1, LCS treatment enhanced cell polarity development, in
terms of both kinetics and maximum polarity, as evidenced
by the steep increase of the number (Figure 4A), as well as
the size (Figure 4B) of the BCs. Similar results were obtained
with another specific inhibitor of serine palmitoyltrans-
ferase, ISP-1/myriocin (unpublished data; c.f. Figure 4). The
opposing effects of LCS and FB1 on polarity development,
under the experimental conditions used, point to sphinga-
nine turnover, rather than to decreased levels of (dihydro)
ceramide and/or complex sphingolipids as a crucial param-
eter in polarity development, a decrease promoting and an
increase inhibiting polarity development. Indeed, the polar-
ity-stimulating effect of LCS treatment was completely abol-
ished in the presence of increasing concentrations of exoge-
nous sphinganine (Figure 4C), whereas exogenous C6-DHC
(Figure 4C) or ceramide (unpublished data) were without
effect.
Dihydroceramide Synthase Is a Target for Cell Polarity-
Stimulating Signaling Cascades
Because the data strongly indicate that the establishment of
HepG2 cell polarity is critically dependent on the level of
sphinganine, we next investigated whether dihydroceram-
ide synthase, the predominant enzyme in sphinganine turn-
over, functions as a target for cellular signals that contribute
to polarity development. For this, we took into account our
previous observation that the stable cAMP analog dbcAMP,
via activation of PKA, stimulates HepG2 cell polarity devel-
opment (Zegers and Hoekstra, 1997; van IJzendoorn and
Hoekstra, 1999a, 2000). Importantly, quantification of sphin-
ganine from cell extracts by ESI-MS/MS revealed that the
cellular sphinganine level was reduced with 63% in db-
cAMP-treated cells, compared with nontreated cells (Table
2), which is in agreement with the observation that reduced
sphinganine levels promote polarity development. To mea-
sure the dihydroceramide synthase activity, control and db-
cAMP-treated HepG2 cells were homogenized, and incu-
bated with [3H]sphinganine and stearyl CoA (at saturating
concentrations) for 10 min. During this time interval, the
activity of DHC synthase was up-regulated 1.5-fold in
dbcAMP-treated cells, as evidenced by the increased pro-
duction of radiolabeled (dihydro)ceramides (22.1  2.4–
32.6  3.8 pmol/mg protein), whereas treatment with FB1
blocked the activity of the enzyme (Figure 5A). Importantly,
whereas dbcAMP typically stimulates polarity development in
HepG2 cells (Figure 5B; c.f. van IJzendoorn and Hoekstra,
1999a, 2000), dbcAMP failed to stimulate polarity development
in dihydroceramide synthase-inhibited or sphinganine-treated
cells (Figure 5B). We conclude that the reduction of cellular free
sphinganine, regulated by signal-mediated modulation of acyl
CoA-dependent dihydroceramide synthase activity is a cru-
cial parameter in cAMP/PKA-stimulated HepG2 cell polar-
ity development.
Sphinganine Interferes with Polarized Membrane Traffic
from SAC
Endogenous cAMP/PKA activity is required for HepG2 cell
polarity development (van IJzendoorn and Hoekstra, 2000),
Figure 3. Effects of various lipids and inhibitors
on HepG2 cell polarity development. Cells were
plated in the presence of exogenous d-erythro-
sphingosine (0.5 M), stearylamine (StAm; 0.5 M),
NH4Cl (0.5 M), or buffer (control) (A) in serum-
supplemented cell culture medium for 24, 48, or
72 h. At each time point, cells were fixed and the
ratio BC/100 cells was determined as described in
Materials and Methods as a measure for cell polarity.
In B, polarity development is shown in control cells
versus cells that were plated in the presence of
l-threo-sphinganine (safingol; 0.5 M), sphinga-
nine-1-phosphate (SA-1-P; 0.5 M), the sphin-
gosine/sphinganine kinase inhibitor DMS (5 M),
FB1 (10 M), or a combination of FB1 (10 M) and
DMS (5 M). Data are expressed as mean  SEM of at least three independent experiments carried out in duplicate. *p  0.05 (Student’s t
test).
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and moreover, it mediates the stimulating effects of interleu-
kin-6 family cytokines on BC biogenesis (van der Wouden et
al., 2002). We previously identified a specific BC (apical
PM)-directed traffic pathway originating from the SAC in
HepG2 cells as a primary target for cAMP/PKA signaling
(van IJzendoorn and Hoekstra, 1999a; van IJzendoorn et al.,
2000). Thus, cAMP/PKA activates a specific SAC-to-BC ve-
sicular traffic route, which is followed by distinct, fluores-
cently labeled lipids, including sphingomyelin and galacto-
sylceramide (GalCer; Figure 6). Inhibition of this route
effectively prohibits polarity development (van IJzendoorn
and Hoekstra, 2000). Because the accumulation of sphinga-
nine prevented dbcAMP-stimulated development of HepG2
cell polarity (Figure 2, A and B), we next investigated
whether the observed effect was directly correlated with a
frustration of cAMP/PKA signaling to redirect and stimu-
late SAC-to-BC membrane trafficking.
To this end, cells were pretreated with FB1 (10 M),
d-erythro-sphinganine (0.5 M), or nothing for 24 h, and SAC
was preloaded with fluorescent GalCer as described in Ma-
terials and Methods (c.f. van IJzendoorn and Hoekstra, 1998,
2000). It is important to note that pretreatment of the cells
with FB1 or sphinganine did not affect basolateral internal-
ization, apical delivery, or transport of the fluorescent probe
from the apical surface to the SAC. After the loading of the
SAC with the fluorescent probe, cells were subsequently
treated with dbcAMP (100 M) or buffer at 4°C, warmed to
37°C, and lipid flow from SAC to either apical (BC) or
basolateral membrane was followed for 20 min. If appropri-
ate, FB1 or sphinganine were kept present during all incu-
bation steps. In control cells, C6NBD-GalCer disappeared
during this time interval from the BCP, which constitutes
SAC (where the lipid is located at t  0) and BC. Indeed, the
percentage of BCP that contained C6NBD-GalCer decreased
in time (Figure 6A, 1 and 2). The relative distribution of the
lipid analogue in the remaining, faintly labeled C6NBD-
GalCer–positive BCP shows that the probe predominantly
resided in SAC and little if any movement from SAC to BC
could be detected (Figure 6, B and C, 1 and 2). Rather, these
data indicate that the probe was transported from SAC to
the basolateral domain of the cells, consistent with previous
observations (van IJzendoorn and Hoekstra, 1999, 2000). By
contrast, in dbcAMP-treated cells, C6NBD-GalCer remained
associated with the BCP region during the 20-min chase, as
evidenced by the unchanged percentage of BCP that con-
tained C6NBD-GalCer (Figure 6A, 1 and 3). Analysis of the
corresponding relative distribution of the probe in the BCP
reveals a flow of the lipid analogue from SAC to BC (Figure
6, B and C, 1 and 3). In striking contrast, dbcAMP failed to
target C6NBD-GalCer from SAC to BC in cells in which
sphinganine turnover was inhibited (Figure 6, B and C, 1
and 4), but not in cells pretreated with LCS, in which the
sphinganine levels are decreased (unpublished data; c.f. Fig-
ure 6, 1 vs. 3). Thus, in cells with elevated sphinganine
levels, C6NBD-GalCer remained associated with the BCP
during the 20-min chase (Figure 6A, 1 and 4), and analysis of
the relative distribution of the lipid analogue in the labeled
BCP revealed that most C6NBD-GalCer localized to SAC
(Figure 6, B and C, 1 and 4), indicating entrapment of the
lipid in SAC. Identical results were obtained when exoge-
Figure 4. LCS promotes HepG2 cell polar-
ity development. Cells were plated in the
presence of different concentrations of LCS,
LCS  DHC, or LCS  sphinganine in se-
rum-supplemented cell culture medium for
24, 48, or 72 h. At each time point, the cells
were fixed, and the ratio BC/100 cells was
determined as described in Materials and
Methods. Effect of 50–250 M LCS (A and B),
250 M LCS  10 M C6-DHC (C), or 250
M LCS  0.5–2.0 M sphinganine (C) on
cell polarity development. Data are ex-
pressed as mean  SEM of at least three
independent experiments carried out in du-
plicate. (B) Fluorescence microscopical eval-
uation of cell polarity in control or LCS-
treated cells (72 h; nuclei in blue and BC in
red). Note the increase in BC circumference
in LCS-treated cells. Bars, 5 m; *p  0.05
(Student’s t test).
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nous sphinganine was added to the cells during the 4°C
dbcAMP treatment before the chase (unpublished data).
These data strongly suggest that dihydroceramide synthase
activity and the subsequent turnover of sphinganine levels is
a prerequisite for cAMP/PKA signaling to redirect polar-
ized membrane traffic from SAC, and in this way, to stimu-
late polarity development.
Sphinganine Inhibits Transcytosis of dIgA-pIgR at the
SAC
Many apical PM proteins reach the apical surface via an
indirect route that includes initial targeting from the Golgi
apparatus to the basolateral surface, followed by transcyto-
sis to the apical domain. The transcytotic pathway involves
passage through distinct compartments. Thus, after basolat-
eral endocytosis, proteins are first delivered to basolateral
early endosomes. Apical PM proteins are then transported
to the SAC, and subsequently, to the apical surface (Rojas
and Apodaca, 2002; Tuma and Hubbard, 2003). We have
previously shown that the cAMP/PKA-activated SAC-to-
apical membrane traffic pathway also is followed by the
transcytosing dIgA-bound polymeric Ig receptor (pIgR; van
IJzendoorn and Hoekstra, 1998) and may thus represent the
final leg of the transcytotic pathway. To investigate whether
accumulation of sphinganine also interfered with dIgA-pIgR
exit from the SAC, HepG2 cells that stably express pIgR (van
IJzendoorn and Hoekstra, 1998) were treated with exoge-
nous d-erythro-sphinganine (0.5 M) or buffer (control) for
30 min at 37°C and incubated with Texas-Red–labeled dIgA
(50 g/ml) at 18°C for 60 min. This allowed the dIgA-pIgR
Figure 6. Accumulation of sphinganine interferes with polarized
membrane trafficking from SAC. SAC of control (A–C, 1–3) or FB1-
treated (24 h; A–C, 4) HepG2 cells were preloaded with C6NBD-
GalCer, as described in detail previously (van IJzendoorn and Hoek-
stra, 1998, 2000). After a subsequent chase, the percentage of C6NBD-
GalCer–positive BCP, comprising BC and/or SAC, was determined
(A), as well as the corresponding relative distribution of the fluorescent
probe in the BCP, i.e., in BC, SAC, or both (BC SAC) (B). 1. Before the
chase (t 0); 2. 20-min chase in HBSS (control cells); 3. 20-min chase in
HBSS  1 mM dbcAMP (control cells); 4, 20-min chase in HBSS  1
mM dbcAMP (FB1-treated cells). Data are expressed as mean SEM of
at least three independent experiments carried out in duplicate. (C)
Representative images showing the distribution of the fluorescent
probe in the BCP area marked by the dashed rectangle (i.e., BC alone,
BC  SAC, or SAC alone). Similar results were obtained when cells
were treated with exogenous sphinganine (0.5 M; 30 min or 24 h)
instead of FB1, but not in cells treated with l-threo-sphinganine, sphin-
gosine, or sphinganine-1-phosphate (all 0.5–2.0M; unpublished data).
Asterisks, BC; arrows, SAC. Bottom panels are phase contrast images
to top panels. Bars, 5 m.
Figure 5. (A) dbcAMP stimulates FB1-sensitive acyl-CoA–depen-
dent DHC activity. Control and dbcAMP-treated (0–24 h) HepG2
cells were homogenized and incubated with [3H]sphinganine (100
pmol/100 g of cell protein) and stearyl-CoA (10 nmol/100 g of
cell protein) for 10 or 0 min at 37°C. Lipids were then extracted with
CHCl3:methanol and separated by TLC. Radiolabeled sphinganine
and (dihydro)ceramides were scraped from the TLC plates and
quantified in a liquid scintillation counter (Veldman et al., 1998).
Note that as negative controls, the omittance of stearyl (St)-CoA
from the reaction or cotreatment of the cells with FB1 prevented
dihydroceramide synthase activity. (B) Increased levels of free sph-
inganine block dbcAMP-stimulated polarity development in HepG2
cells. Cells were cultured in the presence of dbcAMP, dbcAMP 
FB1 (10 M), or dbcAMP  exogenous sphinganine (SA; 0.5 M) in
serum-supplemented culture medium for 24 h. Cells were then
fixed and the ratio BC/100 cells was determined as described in
Materials and Methods. Note the increase in polarity in dbcAMP-
treated cells and the decrease in polarity development in cells
treated with dbcAMP together with FB1 or exogenous sphinganine,
compared with untreated control cells. Data are expressed as
mean  SEM of at least three independent experiments carried out
in duplicate.
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to be internalized and transported to the SAC. Exit from the
SAC, however, is greatly impaired at 18°C (Figure 7A; cf.
van IJzendoorn and Hoekstra, 1998). Treatment of the cells
with sphinganine did not affect basolateral endocytosis and
transport to SAC (Figure 7A). Then, cells were warmed to
37°C and dIgA-pIgR was chased for another 30 min in
buffer, supplemented or not with sphinganine. In control
cells, dIgA-pIgR moved from the SAC to the apical PM
domain (Figure 7B), clearly marking the BC circumference,
in agreement with our previous data (van IJzendoorn and
Hoekstra, 1998). In striking contrast, in sphinganine-treated
cells, transport of dIgA-pIgR from the SAC to the apical
surface was blocked and the protein accumulated in the SAC
(Figure 7C). Similar results were obtained when cells were
treated with FB1 (10 M) or DMS (5 M), whereas treatment
with sphingosine, l-threo-sphinganine or sphinganine-1-
phosphate did not mimic the effects of sphinganine on dIgA-
pIgR transport (unpublished data). These data indicate that
accumulation of sphinganine frustrates the final leg in the
transcytotic pathway, i.e., trafficking from SAC to the apical
PM domain.
DISCUSSION
In this study, we implicate regulated sphinganine metabo-
lism as a prominent parameter in cell polarity development.
The most direct evidence is provided by the observation that
elevated levels of sphinganine, generated either by inhibit-
ing dihydroceramide synthase (sphinganine N-acyltrans-
ferase), by inhibiting sphinganine kinase, or by administer-
ing exogenous d-erythro-, but not l-threo-sphinganine,
effectively and reversibly perturb the de novo biogenesis of
apical PM domains in well differentiated HepG2 cells (Fig-
ures 2 and 3). Moreover, cAMP/PKA signaling cascades that
stimulate cell polarity development significantly increase
the activity of dihydroceramide synthase (Figure 5), and
subsequently, sphinganine turnover, which results in re-
duced cellular sphinganine levels (Table 2). Importantly,
FB1-mediated inhibition of dihydroceramide synthase activ-
ity effectively blocked the stimulatory effect of cAMP/PKA
signaling on polarity development. The molecular mecha-
nism by which cAMP/PKA signaling increases dihydrocer-
amide synthase activity remains to be investigated. Possibly,
cAMP/PKA directly phosphorylates dihydroceramide syn-
thase, or alternatively, it may affect its localization, as dem-
onstrated for other endoplasmic reticulum/Golgi enzymes,
thus affecting substrate clearance. To our knowledge, this is
the first report of regulated dihydroceramide synthase ac-
tivity in response to signaling factors.
Inhibition of dihydroceramide synthase with FB1 resulted
in a decrease in ceramides, sphingomyelin, and glycosphin-
golipids on the one hand, and an increase in cellular sphin-
ganine levels on the other. Because (glyco)sphingolipids
have been implicated in cell differentiation and the biogen-
esis of specialized PM domains in neurons and epithelial
cells, we initially thought that the reduction of cellular (gly-
co)sphingolipids in FB1-treated cells was responsible for the
inhibition of polarity development. However, the opposing
effects of FB1 and LCS treatment on polarity development,
both of which result in decreased levels of higher sphin-
golipids but have opposite effects on sphinganine levels
(Table 2), strongly suggest that the cellular levels of sph-
inganine, rather than the reduced levels of higher sphin-
golipids mediated the effect of dihydroceramide synthase ac-
tivity modulation on polarity development. This is supported
by the observation that exogenous addition of d-erythro-, but
not l-threo-sphinganine, closely mimicked the effect of the di-
hydroceramide synthase inhibitor FB1 in a dose-dependent
manner and that the replenishment of ceramides failed to
restore the inhibitory effects of FB1 (Figure 2). Because inhibi-
tion of sphinganine kinase activity with DMS failed to prevent
the effects of FB1, and because treatment of the cells with
exogenously added sphinganine-1-phosphate did not mimic
the effects of exogenously added sphinganine (Figure 3), we
conclude that sphinganine, rather than its phosphorylated
products, is responsible for the effects described in this study.
The profound effects that an altered level of sphinganine has on
cell surface dynamics may provide for a mechanism that un-
derlies the hepatotoxic effects of fumonisin B1 (Marasas et al.,
1995) and explains the role of fumonsins in hepatocellular
carcinogenesis (Gelderblom et al., 1988; Spiegel and Merrill,
1996), which arises from the dedifferentiation of mature hepa-
tocytes (Bralet et al., 2002; Gournay et al., 2002).
Polarized membrane trafficking and the plasticity thereof is a
crucial factor in cell differentiation (reviewed in Mostov et al.,
2003). Sphingolipids and their precursors, ceramides and
sphingoid bases, have recently emerged as important, but
poorly understood modulators of membrane traffic. In yeast,
sphingoid bases are involved in endocytosis (Friant et al., 2000,
2001; Zanolari et al., 2000; deHart et al., 2002). Here, we show
that elevated levels of sphinganine dramatically perturb polar-
ized membrane traffic from the SAC (Figures 6 and 7), a sub-
Figure 7. Sphinganine inhibits transcytosis
of dIgA-pIgR. HepG2 cells that stably express
pIgR were treated with 2.0 M sphinganine
(C) or buffer (A and B) for 30 min at 37°C and
incubated with Texas Red–labeled dIgA at
18°C for 60 min to accumulate the ligand in
SAC (A). Cells were subsequently shifted to
37°C and incubated for another 30 min in
buffer in the absence (B) or presence (C) of 0.5
M sphinganine. Note that most of the dIgA-
pIgR associated with SAC (A, arrows) is
readily transported to the BC (B, asterisk),
whereas in cells treated with exogenous sph-
inganine, dIgA-pIgR is not transported to the
BC and is retained in SAC (C, arrows; see
text). Treatment of the cells with sphingosine,
l-threo-sphinganine, or sphinganine-1-phos-
phate for 30 min at 37°C gave similar results
as observed in control cells (unpublished
data; c.f. B). Bars, 5 m.
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apical endosomal compartment in epithelial cells that plays a
prominent role in polarized PM recycling and the biogenesis
and dynamics of apical PM domains in hepatocytes (Ihrke et
al., 1998; van IJzendoorn and Hoekstra, 1998, 1999a,b, 2000).
Thus, cAMP/PKA signaling precludes the exit of C6-NBD-
GalCer from SAC in a basolateral PM-directed route and acti-
vates its targeting to the apical PM domain (Figure 6). This
reorganization of polarized membrane traffic from SAC was
previously shown to be a crucial parameter in cell polarity
development in HepG2 cells (van IJzendoorn and Hoekstra,
1999b, 2000). Conditions that promote sphinganine accumula-
tion, i.e., dihydroceramide synthase inhibition or the exoge-
nous addition of sphinganine, but not the exogenous addition
of the nonnatural l-threo-sphinganine or sphinganine-1-phos-
phate, effectively block the cAMP/PKA-mediated activation of
the SAC-to-BC pathway (see model in Figure 8). Exit of the
lipid analogue from SAC in a basolateral direction also is
precluded, thus resulting in its entrapment in SAC. These data
suggest that the cAMP/PKA signaling-stimulated rerouting of
C6-NBD-GalCer includes two distinct events within SAC. The
first step precludes exit from SAC into a vesicular basolateral
PM-directed pathway and the second step involves the activa-
tion of or entry of the lipid into the SAC-to-BC route. That the
exit of the probe into a basolateral PM-directed pathway is
precluded also under conditions of accumulated sphinganine
suggests that the sphingoid base interferes with membrane
traffic from SAC, rather than directly with the cAMP/PKA
signaling cascade. Importantly, because SAC was readily
loaded with C6-NBD-GalCer (Figure 6, A–C, 1), a procedure
that involves basolateral endocytosis, apical delivery, and api-
cal-to-SAC transport of the probe (van IJzendoorn and Hoek-
stra, 1999a, 2000), the effect of sphinganine accumulation on
membrane traffic does not seem to reflect a general frustration
of all intracellular transport but is rather specific to transport
events mediated by SAC. We previously proposed that the
SAC-to-BC pathway activated by cAMP/PKA signaling may
represent the final leg in the basolateral-to-apical transcytotic
route (van IJzendoorn et al., 1999a). The observation that accu-
mulated sphinganine similarly frustrates SAC-to-BC trafficking
of transcytosing dIgA-pIgR (Figure 7) supports this hypothesis.
Although our data strongly suggest that elevated levels of
sphinganine perturb apical PM biogenesis by frustrating po-
larized membrane traffic from the SAC, thereby interfering
with the involvement of SAC as part of the transcytotic itiner-
ary, the mechanism by which sphinganine affects SAC remains
unclear. Sphinganine was reported to perturb endosomal cho-
lesterol transport (Underwood et al., 1996), which results in the
accumulation of cholesterol in perinuclear vesicles (Roff et al.,
1991; Porpaczy et al., 1997), thereby mimicking the endosomal
accumulation of cholesterol and other (sphingo)lipids in Ni-
emann-Pick Type C (Roff et al., 1991; Rodriguez-Lafrasse et al.,
1994) and several sphingolipid storage diseases (Pagano et al.,
2000). A potential interference of sphinganine with cholesterol
trafficking by virtue of its action as a hydrophobic amine,
however, is likely to be excluded, because other hydrophobic
amines did not mimic the effects of sphinganine accumulation
on HepG2 cell polarity development (Figure 3A). Further stud-
ies are needed to clarify the molecular mechanism by which
sphinganine interferes with intracellular membrane trafficking.
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